Mark Howard Snyder - 12 Jun 2026 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Jun 2026, 16:09:46 UTC
Prior SEC filing
24 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James R. Oehler, Attorney-in-Fact

Key filing fact

Mark Howard Snyder filed Form 4 for HALOZYME THERAPEUTICS, INC. (HALO) on 15 Jun 2026.

Key facts

  • This page summarizes Mark Howard Snyder's Form 4 filing for HALOZYME THERAPEUTICS, INC. (HALO).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Jun 2026, 16:09.

Change

  • Previous filing in this sequence was filed on 24 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001902866 Primary reporting owner

Snyder Mark Howard

Relationship
SVP, CHIEF LEGAL OFFICER
Address
C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO
Signature
/s/ James R. Oehler, Attorney-in-Fact
Signature date
15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HALO transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,034
Change %
+11%
Price
$0.000000*
Shares after
52,644
Date
12 Jun 2026
Ownership
Direct
HALO transaction

Common Stock

Tax liability

Transaction value
Shares
-2,715
Change %
-5.2%
Price
$69.50*
Shares after
49,929
Date
12 Jun 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HALO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-5,034
Change %
-33%
Price
$0.000000*
Shares after
10,068
Date
12 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,034
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported disposition of 2,715 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.

Footnote F2

This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .